HLS Net Income from 2010 to 2026
| HLS Stock | CAD 4.65 0.05 1.06% |
Net Loss | First Reported 1997-03-31 | Previous Quarter -2.7 M | Current Value -3.9 M | Quarterly Volatility 3.9 M |
Check HLS Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HLS Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 13.2 M, Interest Expense of 12.2 M or Total Revenue of 55.7 M, as well as many indicators such as Price To Sales Ratio of 1.19, Dividend Yield of 0.0102 or PTB Ratio of 0.73. HLS financial statements analysis is a perfect complement when working with HLS Therapeutics Valuation or Volatility modules.
HLS | Net Income |
Latest HLS Therapeutics' Net Income Growth Pattern
Below is the plot of the Net Income of HLS Therapeutics over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in HLS Therapeutics financial statement analysis. It represents the amount of money remaining after all of HLS Therapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is HLS Therapeutics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in HLS Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (19.66 M) | 10 Years Trend |
|
Net Income |
| Timeline |
HLS Net Income Regression Statistics
| Arithmetic Mean | (7,564,014) | |
| Geometric Mean | 11,101,239 | |
| Coefficient Of Variation | (195.58) | |
| Mean Deviation | 12,942,165 | |
| Median | (13,117,000) | |
| Standard Deviation | 14,793,678 | |
| Sample Variance | 218.9T | |
| Range | 44.4M | |
| R-Value | (0.86) | |
| Mean Square Error | 61.9T | |
| R-Squared | 0.73 | |
| Significance | 0.000011 | |
| Slope | (2,511,237) | |
| Total Sum of Squares | 3501.6T |
HLS Net Income History
About HLS Therapeutics Financial Statements
HLS Therapeutics investors utilize fundamental indicators, such as Net Income, to predict how HLS Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -17.7 M | -16.8 M | |
| Net Loss | -17.7 M | -18.6 M | |
| Net Loss | -17.7 M | -18.6 M | |
| Net Loss | (0.71) | (0.67) | |
| Net Income Per E B T | 1.45 | 1.36 |
Other Information on Investing in HLS Stock
HLS Therapeutics financial ratios help investors to determine whether HLS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HLS with respect to the benefits of owning HLS Therapeutics security.